Simplify Logo

Full-Time

Senior Staff Accountant

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior

Fishers, IN, USA

Category
Cost Accounting
Financial Accounting
Financial Analysis
Management Accounting
Accounting
Required Skills
SAP Products
Mergers & Acquisitions (M&A)
Requirements
  • Bachelor's degree in Finance or Accounting, MBA preferred.
  • Certified Public Accountant or equivalent certification highly preferred.
  • 5-7 years of progressive accounting experience, including a solid background in financial reporting, general ledger management, and month-end/year-end processes.
  • Experience with international accounting standards or working in a global organization.
  • Strong proficiency in SAP or other accounting software programs.
  • Excellent analytical, problem-solving, and detail-oriented skills.
  • Demonstrated involvement in mergers and acquisitions with an understanding of closing/purchase price accounting transactions.
  • Excellent communication and organizational skills.
Responsibilities
  • Ensure timely recording, analyzing and reporting of accounting transactions.
  • Ensure full and complete balancing of intercompany transactions to allow for proper elimination at group level.
  • Co-lead and participate in month-end and year-end close activities, including journal entry posting, reconciliations, accruals, and financial reporting.
  • Complete inventory confirmations, journal entries and transfer pricing transactions within the accounting system.
  • Partner with FP&A team to analyze monthly activity to explain reporting variances and enhance forecasting.
  • Collaborate with various teams and team members regarding SOX compliance activities, internal and external audits.
  • Provide back-up and support for other accountants and ensure proper cross training.
  • Assist in purchase price accounting transactions and opening balance sheet for mergers and acquisitions.
  • Understand and support revenue recognition in accordance with ASC606 and IFRS 15.
  • Understand, support and record transactions related to right our use assets, leases, ASC842.
  • Understand, support, record and reconcile transactions related to various tangible and intangible assets.
  • Develop and maintain documentation related to accounting policies and procedures, ensuring alignment with company guidelines and best practices.
  • Support the review of financial statements for a variety of legal entities, in multiple currencies, to ensure completeness and accuracy of financial data in compliance with accounting standards, GAAP & IFRS.
  • Stay abreast of changes in accounting standards and regulations, evaluating their impact on the organization, and implementing necessary adjustments.
  • Collaborate with stakeholders to provide guidance on financial principles and address any related inquiries or concerns.
  • Embody a shared services mindset to work cross functionally and with a variety of teams.
  • Participate in cross-functional initiatives and projects aimed at improving processes, systems, and controls.
  • Ensure adherence to regulatory requirements, accounting standards, and internal controls related to revenue recognition and rebate programs.
  • Assist in internal and external audits by providing documentation, explanations, and support related to revenue and revenue related processes, controls, and compliance.
  • Implement corrective actions and improvements based on audit findings and recommendations.
  • All other duties as assigned, which may change from time to time to meet business needs.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases using targeted radiation. Their products work by delivering precise radiation to affected areas, which helps in making better treatment decisions and providing personalized therapy. Unlike many other biopharmaceutical companies, Telix focuses specifically on areas such as urologic oncology, neuro-oncology, musculoskeletal oncology, and bone marrow conditioning, addressing significant unmet medical needs. The company's goal is to enhance patient care while maintaining ethical practices and environmental responsibility, ensuring that they create sustainable value for patients, shareholders, and employees.

Company Stage

Grant

Total Funding

$63.5M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

12%

1 year growth

27%

2 year growth

90%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.